Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)
ConclusionsIn the IQVIA ™ LRx database, patients prescribed tafamidis 61 mg in Germany displayed high adherence and persistency rates, which suggest good drug tolerability and ease of use.
Source: Cardiology and Therapy - Category: Cardiology Source Type: research
More News: Cardiology | Cardiomyopathy | Cardiovascular | Databases & Libraries | Germany Health | Health Insurance | Heart | Insurance | Study